Your session is about to expire
← Back to Search
Smart Scale Usage and Evaluation for Head and Neck Cancer
N/A
Recruiting
Led By Ravi Chandra
Research Sponsored by OHSU Knight Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 3 months post-radiation therapy
Awards & highlights
Study Summary
This trial is testing whether "smart" body-weight scales can help monitor weight and nutrition in patients with head and neck cancer undergoing radiation therapy.
Eligible Conditions
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- Head and Neck Cancers
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 3 months post-radiation therapy
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 3 months post-radiation therapy
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Adherence to treatment
Secondary outcome measures
MD Anderson Symptom Inventory for Head and Neck Cancer (MDASI-HN) questionnaire scores
Overall pain scores
Weight loss percentage
Side effects data
From 2020 Phase 3 trial • 177 Patients • NCT0181707513%
Rash maculo-papular
10%
Skin and subcutaneous tissue disorders - Other, specify
1%
Mucositis oral
1%
Sepsis
1%
Skin ulceration
1%
Urticaria
100%
80%
60%
40%
20%
0%
Study treatment Arm
Arm I (CHG Cleansing Wipe)
Arm II (Control)
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Cohort I ('Smart" scale weighing)Experimental Treatment2 Interventions
Patients weigh themselves daily using the "Smart" scale over 5-8 weeks during standard radiation therapy.
Group II: Cohort 2 (no weighing)Active Control1 Intervention
Patients do not weigh themselves using the "Smart" scale during standard radiation therapy.
Find a Location
Who is running the clinical trial?
Cambia Health FoundationUNKNOWN
3 Previous Clinical Trials
203 Total Patients Enrolled
OHSU Knight Cancer InstituteLead Sponsor
230 Previous Clinical Trials
2,090,706 Total Patients Enrolled
Oregon Health and Science UniversityOTHER
973 Previous Clinical Trials
6,846,009 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- Participants have a type of cancer that can potentially be cured with radiation therapy.You do not have a confirmed diagnosis of cancer based on tissue examination.You do not want or will not receive radiation therapy to treat your cancer.
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Research Study Groups:
This trial has the following groups:- Group 1: Cohort 2 (no weighing)
- Group 2: Cohort I ('Smart" scale weighing)
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any remaining slots available for participants in this investigation?
"Data hosted on clinicaltrials.gov reveal that this medical study is currently inactive, despite being initially posted in September of 2022 and updated as recently as July 11th. Even so, there are 929 other trials actively recruiting patients right now."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger